CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.0858
+0.0043 (5.28%)
At close: Oct 31, 2024, 4:00 PM
0.0800
-0.0058 (-6.76%)
After-hours: Oct 31, 2024, 7:28 PM EDT

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1369236223
Market Cap Growth
-93.90%-70.89%6.05%-
Enterprise Value
2070236-
Last Close Price
0.0811.0010.279.91
PE Ratio
--28.32-345.96-
PB Ratio
-1.81-4.84-21.46-29.02
P/FCF Ratio
-0.68-45.10-216.09-186.24
P/OCF Ratio
-0.68-45.10-216.09-186.24
EV/EBIT Ratio
-1.53-23.86-81.06-
EV/FCF Ratio
-1.80-45.93-215.63-
Debt / Equity Ratio
-0.87-0.11-0.06-
Debt / FCF Ratio
-0.32-1.02-0.60-
Quick Ratio
0.430.020.0211.20
Current Ratio
0.481.651.3813.88
Return on Assets (ROA)
-45.28%-7.20%-1.63%-
Earnings Yield
-22.48%-3.69%-0.28%-0.24%
FCF Yield
-54.12%-2.22%-0.46%-0.54%
Buyback Yield / Dilution
41.71%70.97%-133.12%-
Total Shareholder Return
41.71%70.97%-133.12%-
Source: S&P Capital IQ. Standard template. Financial Sources.